$1.95
0.02[1.04%]
At close: Apr 24
$1.95
0[0.00%]
After Hours: 4:25PM EDT
Cognition Therapeutics
(NASDAQ:CGTX)Latest News for Cognition Therapeutics Stock (NASDAQ:CGTX)
Cognition Therapeutics Stock (NASDAQ: CGTX)
Categories: All
Monday, April 22, 2024
Thursday, March 28, 2024
Wednesday, March 27, 2024
Tuesday, March 26, 2024
- Cognition Therapeutics Q4 EPS $(0.27) Beats $(0.34) EstimateHappy Mohamed - Mar 26, 2024, 9:28AM
- Cognition Therapeutics Reports FY23 Net Loss Per Share Of $(0.86) Compared With $(0.91) YoY, Cash And Equivalents As Of December 31, 2023, Were Approximately $29.9MBenzinga Newsdesk - Mar 26, 2024, 7:10AM
- Earnings Scheduled For March 26, 2024Benzinga Insights - Mar 26, 2024, 4:47AM
Monday, March 25, 2024
Friday, March 15, 2024
Tuesday, March 12, 2024
Monday, March 11, 2024
Tuesday, February 06, 2024
Wednesday, January 17, 2024
Thursday, January 11, 2024
Thursday, January 04, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Jan 4, 2024, 4:31PM
- Cognition Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 17/537,110 Titled "Compositions For Treating Neurodegenerative Diseases (Including Alzheimer's Disease And Cognitive Decline)"Benzinga Newsdesk - Jan 4, 2024, 12:41PM
Monday, December 11, 2023
Monday, December 04, 2023
Wednesday, November 15, 2023
Tuesday, November 07, 2023
Thursday, November 02, 2023
- Cognition Therapeutics Cash And Cash Equivalents As Of September 30, 2023, Were Approximately $33.0 Million, And Total Grant Funds Remaining From The NIA Were $74.3 Million, Expected To Provide Cash Runway Through November Of 2024Benzinga Newsdesk - Nov 2, 2023, 7:59AM
- Cognition Therapeutics Q3 EPS $(0.22) Beats $(0.24) EstimateBenzinga Newsdesk - Nov 2, 2023, 7:57AM
Friday, October 27, 2023
- Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 27, 2023, 8:14AM
- Cognition Therapeutics And Collaborators At Yale And ACTC Announce Oral Late-breaking Presentation On The START Study In Early Alzheimer's Disease At CTADBenzinga Newsdesk - Oct 27, 2023, 7:31AM
Thursday, October 26, 2023
- Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Oct 26, 2023, 1:27PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Oct 26, 2023, 9:06AM
- Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 26, 2023, 8:53AM
Wednesday, October 25, 2023
Tuesday, October 24, 2023
Monday, October 16, 2023
Monday, August 14, 2023
Tuesday, August 08, 2023
Monday, August 07, 2023
Tuesday, July 11, 2023
Thursday, July 06, 2023
Wednesday, June 28, 2023
- Crude Oil Rises Sharply; Unifirst Earnings Miss ExpectationsLisa Levin - Jun 28, 2023, 2:39PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jun 28, 2023, 1:37PM
- Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jun 28, 2023, 1:04PM
- Nasdaq Moves Higher; US Crude Stocks Drop More than ProjectedLisa Levin - Jun 28, 2023, 12:22PM
- Why Cognition Therapeutics Stock Is Plunging On Alzheimer's Disease Related News TodayVandana Singh - Jun 28, 2023, 11:40AM
- Cognition Therapeutics shares are trading lower after the company released topline data from Phase 2 SEQUEL Study Of CT1812 in 16 adults with mild-to-moderate Alzheimer's diseaseBenzinga Newsdesk - Jun 28, 2023, 10:10AM
- Dow Drops 100 Points; General Mills Posts Downbeat SalesLisa Levin - Jun 28, 2023, 9:52AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jun 28, 2023, 9:12AM
- Cognition Therapeutics Announced Topline Results From Its Phase 2 SEQUEL Study Of Ct1812 In 16 Adults With Mild-To-Moderate Alzheimer's Disease, Meeting Its Primary Endpoints For Safety And TolerabilityBenzinga Newsdesk - Jun 28, 2023, 7:03AM